FacialBeau International Corporation (FACIALBEAU), a biomedical enterprise under Pegatron Group, was established in October 2021. Adhering to its philosophy of combining “sensible technology” and “sentimental art”, the company takes a scientific approach to fully embody sublime aesthetics in all its products. To demonstrate its commitment to entering the medical aesthetics sector, the company assembled a team from former biomedical R&D employees of Taiwan’s Industrial Technology Research Institute to establish the FACIALBEAU Research Institute, setting up front-end and back-end ingredient and product R&D centers in Hsinchu and Xin Zhuang. FACIALBEAU also cooperates with domestic and foreign academic R&D institutions and medical centers to develop competitive products.